Racotumomab (Idiotope van anti- (N-glycolylneuraminezuur (NeuGc, NGNA) -gangliosides GM3) Musmusculus IgM-kappa monoklonaal antilichaam P3) - Onderzoeksklasse Biosimilar
Gecertificeerd

Racotumomab (Idiotope van anti- (N-glycolylneuraminezuur (NeuGc, NGNA) -gangliosides GM3) Musmusculus IgM-kappa monoklonaal antilichaam P3) - Onderzoeksklasse Biosimilar

Catalog #: 10-247
Maat: 0.1 mg

Kwaliteit

ISO Gecertificeerd

Levering

24-48 uur

Prijs -1%
Login voor prijs
BTW niet inbegrepen
Gratis verzending vanaf €100
Technische Documentatie

Technische Specificaties

Background

Racotumomab has been used in trials studying the treatment of Glioma, Wilm's Tumor, Neuroblastoma, Retinoblastoma, and Ewing's Sarcoma.

Immunogen

Mus musculus / Idiotope of anti- (N-glycolylneuraminic acid (NeuGc, NGNA) -gangliosides GM3) Mus musculus IgM-kappa monoclonal antibody P3 [Homo sapiens]

Clonality

• Recombinant Monoclonal

Conjugation

Unconjugated

Type

Primary Antibodies, Biosimilars

Source

CHO cells

Field of Research

Cancer

Purification

>95%

Concentration

Batch dependent

Buffer

PBS buffer pH7.5

Modification

None

Shipping Conditions

Blue Ice

Storage Conditions

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.

Fragment

IgG1-kappa

NCBI Organism

Homo sapiens

Beschrijving

Racotumomab (Idiotope van anti- (N-glycolylneuraminezuur (NeuGc, NGNA) -gangliosides GM3) Musmusculus IgM-kappa monoklonaal antilichaam P3) - Onderzoeksklasse B

Specificaties

ProductnaamRacotumomab (Idiotope van anti- (N-glycolylneuraminezuur (NeuGc, NGNA) -gangliosides GM3) Musmusculus IgM-kappa monoklonaal antilichaam P3) - Onderzoeksklasse Biosimilar
Categorie
Beschikbare grootte0.1 mg
Catalogusnummer10-247